Mizoribine for the treatment of lupus nephritis in children and adolescents

Abstract

Although this case series is without controls, maintenance therapy with MZR administered in combination with PSL may be beneficial and clinically less toxic in at least a proportion of pubertal patients with lupus nephritis.